These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 7560609
1. Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. Wei K, Dorian P, Newman D, Langer A. J Am Coll Cardiol; 1995 Oct; 26(4):859-63. PubMed ID: 7560609 [Abstract] [Full Text] [Related]
2. Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy. Langen KJ, Ziegler D, Weise F, Piolot R, Boy C, Hübinger A, Gries FA, Müller-Gärtner HW. Clin Sci (Lond); 1997 Oct; 93(4):325-33. PubMed ID: 9404224 [Abstract] [Full Text] [Related]
3. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. Langer A, Freeman MR, Josse RG, Armstrong PW. J Am Coll Cardiol; 1995 Mar 01; 25(3):610-8. PubMed ID: 7860904 [Abstract] [Full Text] [Related]
4. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia. Matsuo S, Takahashi M, Nakamura Y, Kinoshita M. J Nucl Med; 1996 May 01; 37(5):712-7. PubMed ID: 8965132 [Abstract] [Full Text] [Related]
5. Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Schnell O, Muhr D, Weiss M, Dresel S, Haslbeck M, Standl E. Diabetes; 1996 Jun 01; 45(6):801-5. PubMed ID: 8635656 [Abstract] [Full Text] [Related]
6. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Schnell O, Kirsch CM, Stemplinger J, Haslbeck M, Standl E. Diabetologia; 1995 Nov 01; 38(11):1345-52. PubMed ID: 8582545 [Abstract] [Full Text] [Related]
7. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. Tanaka M, Hongo M, Kinoshita O, Takabayashi Y, Fujii T, Yazaki Y, Isobe M, Sekiguchi M. J Am Coll Cardiol; 1997 Jan 01; 29(1):168-74. PubMed ID: 8996310 [Abstract] [Full Text] [Related]
8. [QT dispersion in insulin-dependent diabetics]. Galetta F, Franzoni F, Prattichizzo F, Tintori G, Cinotti F, Taccola D, Giusti C. G Ital Cardiol; 1999 Jun 01; 29(6):675-8. PubMed ID: 10396672 [Abstract] [Full Text] [Related]
9. [Value of scintigraphy using meta-iodo-benzyl-guanidine (MIBG) in the investigation of cardiac autonomic neuropathy in diabetic patients. Comparison with Ewing tests]. Cosson E, Mayaudon H, Ducorps M, Gaillard JF, Foehrenbach H, Pellan M, Prevost G, Bauduceau B. Arch Mal Coeur Vaiss; 1997 Aug 01; 90(8):1055-8. PubMed ID: 9404408 [Abstract] [Full Text] [Related]
10. Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM. Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MI. Diabetes Care; 1996 Oct 01; 19(10):1083-90. PubMed ID: 8886553 [Abstract] [Full Text] [Related]
11. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy. Sacre JW, Franjic B, Coombes JS, Marwick TH, Baumert M. J Cardiovasc Electrophysiol; 2013 Mar 01; 24(3):305-13. PubMed ID: 23210722 [Abstract] [Full Text] [Related]
13. Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG. Giordano A, Calcagni ML, Verrillo A, Pellegrinotti M, Frontoni S, Spallone V, Gambardella S. Diabetes Nutr Metab; 2000 Dec 01; 13(6):350-5. PubMed ID: 11232761 [Abstract] [Full Text] [Related]
14. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus. Schnell O, Muhr D, Weiss M, Kirsch CM, Haslbeck M, Tatsch K, Standl E. J Diabetes Complications; 1997 Dec 01; 11(5):307-13. PubMed ID: 9334913 [Abstract] [Full Text] [Related]
15. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability. Murata K, Sumida Y, Murashima S, Matsumura K, Takeda H, Nakagawa T, Shima T. Diabet Med; 1996 Mar 01; 13(3):266-72. PubMed ID: 8689849 [Abstract] [Full Text] [Related]
16. Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Ziegler D, Weise F, Langen KJ, Piolot R, Boy C, Hübinger A, Müller-Gärtner HW, Gries FA. Diabetologia; 1998 Apr 01; 41(4):443-51. PubMed ID: 9562349 [Abstract] [Full Text] [Related]
17. Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine. Kim SJ, Lee JD, Ryu YH, Jeon P, Shim YW, Yoo HS, Park CY, Lim SG. Eur J Nucl Med; 1996 Apr 01; 23(4):401-6. PubMed ID: 8612660 [Abstract] [Full Text] [Related]
18. Cardiac autonomic dysfunction in Brugada syndrome. Wichter T, Matheja P, Eckardt L, Kies P, Schäfers K, Schulze-Bahr E, Haverkamp W, Borggrefe M, Schober O, Breithardt G, Schäfers M. Circulation; 2002 Feb 12; 105(6):702-6. PubMed ID: 11839625 [Abstract] [Full Text] [Related]
19. Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus. Mäntysaari M, Kuikka J, Mustonen J, Tahvanainen K, Vanninen E, Länsimies E, Uusitupa M. Clin Auton Res; 1996 Jun 12; 6(3):163-9. PubMed ID: 8832126 [Abstract] [Full Text] [Related]